Literature DB >> 26148237

Structural basis of how stress-induced MDMX phosphorylation activates p53.

X Chen1,2, N Gohain1, C Zhan1, W-Y Lu2, M Pazgier1, W Lu1,3.   

Abstract

The tumor-suppressor protein p53 is tightly controlled in normal cells by its two negative regulators--the E3 ubiquitin ligase MDM2 and its homolog MDMX. Under stressed conditions such as DNA damage, p53 escapes MDM2- and MDMX-mediated functional inhibition and degradation, acting to prevent damaged cells from proliferating through induction of cell cycle arrest, DNA repair, senescence or apoptosis. Ample evidence suggests that stress signals induce phosphorylation of MDM2 and MDMX, leading to p53 activation. However, the structural basis of stress-induced p53 activation remains poorly understood because of the paucity of technical means to produce site-specifically phosphorylated MDM2 and MDMX proteins for biochemical and biophysical studies. Herein, we report total chemical synthesis, via native chemical ligation, and functional characterization of (24-108)MDMX and its Tyr99-phosphorylated analog with respect to their ability to interact with a panel of p53-derived peptide ligands and PMI, a p53-mimicking but more potent peptide antagonist of MDMX, using FP and surface plasmon resonance techniques. Phosphorylation of MDMX at Tyr99 weakens peptide binding by approximately two orders of magnitude. Comparative X-ray crystallographic analyses of MDMX and of pTyr99 MDMX in complex with PMI as well as modeling studies reveal that the phosphate group of pTyr99 imposes extensive steric clashes with the C-terminus of PMI or p53 peptide and induces a significant lateral shift of the peptide ligand, contributing to the dramatic decrease in the binding affinity of MDMX for p53. Because DNA damage activates c-Abl tyrosine kinase that phosphorylates MDMX at Tyr99, our findings afford a rare glimpse at the structural level of how stress-induced MDMX phosphorylation dislodges p53 from the inhibitory complex and activates it in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26148237      PMCID: PMC5470632          DOI: 10.1038/onc.2015.255

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

Review 1.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

Review 2.  Protein semisynthesis and expressed protein ligation: chasing a protein's tail.

Authors:  Dirk Schwarzer; Philip A Cole
Journal:  Curr Opin Chem Biol       Date:  2005-10-13       Impact factor: 8.822

3.  Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.

Authors:  Grzegorz M Popowicz; Anna Czarna; Tad A Holak
Journal:  Cell Cycle       Date:  2008-05-27       Impact factor: 4.534

Review 4.  The structure-based design of Mdm2/Mdmx-p53 inhibitors gets serious.

Authors:  Grzegorz M Popowicz; Alexander Dömling; Tad A Holak
Journal:  Angew Chem Int Ed Engl       Date:  2011-02-21       Impact factor: 15.336

5.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

Review 6.  Awakening guardian angels: drugging the p53 pathway.

Authors:  Christopher J Brown; Sonia Lain; Chandra S Verma; Alan R Fersht; David P Lane
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

7.  Expressed protein ligation: a general method for protein engineering.

Authors:  T W Muir; D Sondhi; P A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 8.  The chemical biology of protein phosphorylation.

Authors:  Mary Katherine Tarrant; Philip A Cole
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

Authors:  Zehavit Goldberg; Ronit Vogt Sionov; Michael Berger; Yaara Zwang; Ruth Perets; Richard A Van Etten; Moshe Oren; Yoichi Taya; Ygal Haupt
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  6 in total

1.  Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.

Authors:  Fan Niu; Jin Yan; Bohan Ma; Shichao Li; Yongping Shao; Pengcheng He; Wanggang Zhang; Wangxiao He; Peter X Ma; Wuyuan Lu
Journal:  Biomaterials       Date:  2018-03-14       Impact factor: 12.479

2.  MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

Authors:  Anna de Polo; Varunika Vivekanandan; John B Little; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

Review 3.  Cross talk of tyrosine kinases with the DNA damage signaling pathways.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Nucleic Acids Res       Date:  2015-11-05       Impact factor: 16.971

Review 4.  Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.

Authors:  Ilaria Moscetti; Salvatore Cannistraro; Anna Rita Bizzarri
Journal:  Sensors (Basel)       Date:  2017-11-20       Impact factor: 3.576

5.  Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53.

Authors:  Jane Vin Chan; Dawn Xin Ping Koh; Yun Liu; Thomas L Joseph; David P Lane; Chandra S Verma; Yaw Sing Tan
Journal:  Oncotarget       Date:  2017-12-01

6.  Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design.

Authors:  Xiang Li; W David Tolbert; Hong-Gang Hu; Neelakshi Gohain; Yan Zou; Fan Niu; Wang-Xiao He; Weirong Yuan; Jia-Can Su; Marzena Pazgier; Wuyuan Lu
Journal:  Chem Sci       Date:  2018-11-30       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.